• news

• World news

• Europe

After Pfizer: Astraznica will reduce vaccine shipments to the EU

According to Reuters, the pharmaceutical company has announced that it will not be able to supply the agreed amount of vaccines due to manufacturing problems at a plant in Belgium.

It will send 31 million parcels to EU countries in the first quarter of this year, 60% less than expected, and failed to commit to targets for the next quarter

Tags

• Astraznica

Reuters

Friday, 22 January 2021, 23:05

• Share on Facebook

• Share on WhatsApp

• Share on general

• Share on general

• Share on Twitter

• Share on Email

0 comments

• The trial of Israeli billionaire Benny Steinmetz: Defendant in providing ...

• Murder in Umm al-Fahm: A 21-year-old man was shot dead on 22.01.21

• Ganz on a tour of the north: We acted against anyone who tried to harm us ...

• 4 detainees in clashes in Umm al-Fahm during a demonstration on ...

• Due to the spread of the corona mutation: Johnson announced that ...

• Report: 23 killed in Israeli attack against militias ...

• The Trump era: the lies, the love for Israel and the unmatched moments ...

• While Nabalani in prison: His staff published an investigation into his palace ...

• Winter weather: rescue in Jerusalem, snow on Mount Hermon and in the mountains ...

In video: UK launches AstraZenica and Oxford vaccination campaign (Photo: Reuters)

The pharmaceutical company Astraznica will reduce vaccines against Corona to the EU by about 60% in the first quarter of the year, so that only 31 million doses will be sent, an EU official told Reuters tonight (Friday).

This is due to manufacturing problems at the vaccine plant in Belgium.

According to the source involved in the talks between the parties, the company was supposed to send about 80 million packages to the 27 member states of the European Union by the end of March.

More on Walla!

NEWS

The treatment for knee pain that returns to full function - without pain

To the full article

60% reduction.

Delivery of Astraznica vaccines (Photo: Reuters)

The company also agreed to ship more than 80 million units in the second quarter, but today failed to commit to specific targets for April and June.

According to the source, the company explained that the reduction came as a result of operational problems at the vaccine plant in Belgium, which is operated by the Novasp company, which works in cooperation with them.

• Share on Facebook

• Share on WhatsApp

• Share on general

• Share on general

• Share on Twitter

• Share on Email

0 comments